IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals Term Loan 2/13/19 Bbg0058046r2

CUSIP: 0058046R2 | 1 institutional holders

Quarters

Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2015

Crow Point Partners, LLC217,714
0.0% of portfolio›$218
StyleTurnoverLocationFiled
Crow Point Partners, LLC
217,714$2180.0%N/AN/AHingham, MA2015-12-17